Immunogenicity and Safety of Boostrix Polio Vaccine as a Booster Dose in 5 to 6-year-old Children.

NCT00871000 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

303

Enrollment

INDUSTRY

Sponsor class

Conditions

Acellular Pertussis
Tetanus
Diphtheria
Poliomyelitis

Interventions

BIOLOGICAL: Boostrix Polio™ 711866
BIOLOGICAL: Priorix Tetra TM 208136
BIOLOGICAL: Tetravac TM

Sponsor

GlaxoSmithKline